CO24 Simulating the Impact of First-Line Treatment Choice on Survival Among Patients with Locally Advanced/Metastatic Urothelial Carcinoma Considered Cisplatin Ineligible
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.098
https://www.valueinhealthjournal.com/article/S1098-3015(23)00198-5/fulltext
Title :
CO24 Simulating the Impact of First-Line Treatment Choice on Survival Among Patients with Locally Advanced/Metastatic Urothelial Carcinoma Considered Cisplatin Ineligible
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00198-5&doi=10.1016/j.jval.2023.03.098
First page :
Section Title :
Open access? :
No
Section Order :
10421